Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

G Comi, P O'Connor, X Montalban, J Antel, E-W Radue, G Karlsson, H Pohlmann, S Aradhye, L Kappos, FTY720D2201 Study Group, Per Soelberg Sørensen, Jette Lautrup Battistini Frederiksen

144 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results'. Together they form a unique fingerprint.

Medicine & Life Sciences